Prevalence and clinical implications of bronchiectasis in patients with overlapping asthma and chronic rhinosinusitis: a single-center prospective study
BackgroundAs a typical "united airway" disease, asthma-chronic rhinosinusitis (CRS) overlap has recently drawn more attention. Bronchiectasis is a heterogeneous disease related to a variety of diseases. Whether bronchiectasis exists and correlates with asthma-CRS patients has not been fully elucidated. The purpose of the study was to explore the presence and characteristics of bronchiectasis in patients with overlapping asthma and CRS.MethodsThis report describes a prospective study with consecutive asthma-CRS patients. The diagnosis and severity of bronchiectasis were obtained by thorax high-resolution computed tomography (HRCT), the Smith radiology scale and the Bhalla scoring system. CRS severity was evaluated by paranasal sinus CT and the Lund-Mackay (LM) scoring system. The correlations between bronchiectasis and clinical data, fraction of exhaled nitric oxide, peripheral blood eosinophil counts and lung function were analyzed.ResultsSeventy-two (40.91%) of 176 asthma-CRS patients were diagnosed with bronchiectasis. Asthma-CRS patients with overlapping bronchiectasis had a higher incidence rate of nasal polyps (NPs) (P=0.004), higher LM scores (P=0.044), higher proportion of >= 1 severe exacerbation of asthma in the last 12 months (P=0.003), lower postbronchodilator forced expiratory volume in one second (FEV1) % predicted (P=0.006), and elevated peripheral blood eosinophil counts (P=0.022). Smith and Bhalla scores were shown to correlate positively with NPs and negatively with FEV1% predicted and body mass index. Cutoff values of FEV1% predicted <= 71.40%, peripheral blood eosinophil counts >0.60x10(9)/L, presence of NPs, and >= 1 severe exacerbation of asthma in the last 12 months were shown to differentiate bronchiectasis in asthma-CRS patients.ConclusionsBronchiectasis commonly overlaps in asthma-CRS patients. The coexistence of bronchiectasis predicts a more severe disease subset in terms of asthma and CRS. We suggest that asthma-CRS patients with NPs, severe airflow obstruction, eosinophilic inflammation, and poor asthma control should receive HRCT for the early diagnosis of bronchiectasis.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81800014]; Beijing Natural Science FoundationBeijing Natural Science Foundation [7212018]
第一作者机构:[1]Capital Med Univ, Beijing Tongren Hosp, Dept Resp & Crit Care Med, 1 Dongjiao Minxiang, Beijing 100730, Peoples R China
共同第一作者:
通讯作者:
通讯机构:[2]Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China[3]Beijing Inst Otolaryngol, Key Lab Otolaryngol Head & Neck Surg, Minist Educ China, 17 Hougou Hutong, Beijing 100005, Peoples R China
推荐引用方式(GB/T 7714):
Sheng Haiyan,Yao Xiujuan,Wang Xiangdong,et al.Prevalence and clinical implications of bronchiectasis in patients with overlapping asthma and chronic rhinosinusitis: a single-center prospective study[J].BMC PULMONARY MEDICINE.2021,21(1):doi:10.1186/s12890-021-01575-7.
APA:
Sheng, Haiyan,Yao, Xiujuan,Wang, Xiangdong,Wang, Yuhong,Liu, Xiaofang&Zhang, Luo.(2021).Prevalence and clinical implications of bronchiectasis in patients with overlapping asthma and chronic rhinosinusitis: a single-center prospective study.BMC PULMONARY MEDICINE,21,(1)
MLA:
Sheng, Haiyan,et al."Prevalence and clinical implications of bronchiectasis in patients with overlapping asthma and chronic rhinosinusitis: a single-center prospective study".BMC PULMONARY MEDICINE 21..1(2021)